San Bruno, CA, United States of America

Devan Naduthambi

This inventor holds 36 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Cancer Therapeutics. Top assignee: Gilead Sciences, Inc.. Active years: 2017-2026.

USPTO Granted Patents = 36 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 11.4

ph-index = 5

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PD-1 Inhibitors
MCL-1 Inhibitors
Phospholipid Compounds
SARS-COV2 Protease Inhibitors
Tank-Binding Kinase
Phosphatidylinositol 3-Kinase
Substituted Pyridotriazines
Prodrugs
Nucleotide Analogues
36 patents (USPTO):Explore Patents

Title: The Innovative Journey of Devan Naduthambi

Introduction: Devan Naduthambi, a talented inventor based in San Bruno, CA, has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Devan Naduthambi holds several patents in various technological domains, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a passion for pushing the boundaries of technology, Devan Naduthambi has had a successful career marked by numerous groundbreaking inventions that have revolutionized the industry.

Collaborations: Throughout his career, Devan Naduthambi has collaborated with leading tech companies, research institutions, and universities to further enhance his innovative ideas and bring them to life.

Conclusion: Devan Naduthambi's dedication to innovation and his remarkable contributions to the technological field make him a standout inventor whose work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…